ResearcherMisawa City HospitalNo recent work listed
Yuh Sakata
Matched on OpenAlex author ID A5109310451. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 3
- Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pa… Co-author DOI 10.3390/jcm12041596↗
- Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan… Co-author DOI 10.1136/bmjopen-2021-048833↗
- Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer. Last author DOI 10.1038/bjc.2016.436↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshito Komatsu · 3 shared papers, 2017–2023 · strength 0.31
- Paper Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotec… DOI 10.3390/jcm12041596↗
- Paper Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination c… DOI 10.1136/bmjopen-2021-048833↗
- Paper Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer. DOI 10.1038/bjc.2016.436↗
- Kazuaki Harada · 2 shared papers, 2022–2023 · strength 0.26
- Paper Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotec… DOI 10.3390/jcm12041596↗
- Paper Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination c… DOI 10.1136/bmjopen-2021-048833↗
- Shintaro Nakano · 2 shared papers, 2022–2023 · strength 0.26
- Paper Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotec… DOI 10.3390/jcm12041596↗
- Paper Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination c… DOI 10.1136/bmjopen-2021-048833↗
- Yasuyuki Kawamoto · 2 shared papers, 2022–2023 · strength 0.26
- Paper Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotec… DOI 10.3390/jcm12041596↗
- Paper Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination c… DOI 10.1136/bmjopen-2021-048833↗
- Naoya Sakamoto · 2 shared papers, 2022–2023 · strength 0.26
- Paper Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotec… DOI 10.3390/jcm12041596↗
- Paper Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination c… DOI 10.1136/bmjopen-2021-048833↗
- Tetsuhito Muranaka · 1 shared paper, 2023 · strength 0.14
- Atsushi Satō · 1 shared paper, 2022 · strength 0.12
- Shinya Kajiura · 1 shared paper, 2022 · strength 0.12
- Shinichi Ohkawa · 1 shared paper, 2017 · strength 0.05
- Haruo Iguchi · 1 shared paper, 2017 · strength 0.05
- Taketo Yamaguchi · 1 shared paper, 2017 · strength 0.05
- C Hamada · 1 shared paper, 2017 · strength 0.05
- Nobumasa Mizuno · 1 shared paper, 2017 · strength 0.05
- Tatsuya Ioka · 1 shared paper, 2017 · strength 0.05
- Junji Furuse · 1 shared paper, 2017 · strength 0.05
- Akihito Tsuji · 1 shared paper, 2017 · strength 0.05
- Masao Tanaka · 1 shared paper, 2017 · strength 0.05
- Takao Itoi · 1 shared paper, 2017 · strength 0.05
- Masayuki Kitano · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.